# ACCENDRA HEALTH INC/VA/

ACCENDRA HEALTH INC/VA/ is a public company listed on NYSE as ACH, headquartered in Glen Allen, VA, United States.

## Company overview

- **Legal name:** ACCENDRA HEALTH INC/VA/
- **Former names in filing history:** OWENS & MINOR INC/VA/ (1994-08-10 to 2025-12-31); O&M HOLDING INC (1994-06-17 to 1994-06-17); OWENS & MINOR INC (1994-04-22 to 1994-03-09)
- **Classification:** Public company
- **Industry (SIC):** 5047 — Wholesale-Medical, Dental & Hospital Equipment & Supplies
- **Headquarters:** Glen Allen, VA, United States
- **Incorporated in:** VA
- **Fiscal year end:** December 31
- **Ticker:** NYSE: ACH
- **SEC CIK:** 0000075252

## About

ACCENDRA HEALTH INC/VA/ is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000075252, and its reported industry is Wholesale-Medical, Dental & Hospital Equipment & Supplies. In 10-K filed on 2026-02-20, it reported annual revenue of USD 2,762,032,000; net income of USD -1,100,642,000; total assets of USD 2,451,761,000 for the fiscal period ended 2025-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2025 (period ended 2025-12-31)

- **Revenue:** $2.8B (USD 2,762,032,000)
- **Net income:** -$1.1B (USD -1,100,642,000)
- **Total assets:** $2.5B (USD 2,451,761,000)
- **Cash and equivalents:** $282.0M (USD 281,989,000)

### FY2024 (period ended 2024-12-31)

- **Revenue:** $10.7B (USD 10,700,883,000)
- **Net income:** -$362.7M (USD -362,686,000)
- **Total assets:** $4.7B (USD 4,656,156,000)
- **Cash and equivalents:** $49.4M (USD 49,382,000)
- **Operating cash flow:** $161.5M (USD 161,495,000)
- **Later filings:** Revenue, Cash and equivalents: shown as originally filed; later filings report different values for the same periods.

### FY2023 (period ended 2023-12-31)

- **Revenue:** $10.3B (USD 10,333,967,000)
- **Net income:** -$41.3M (USD -41,301,000)
- **Total assets:** $5.1B (USD 5,093,322,000)
- **Cash and equivalents:** $243.0M (USD 243,037,000)
- **Operating cash flow:** $740.7M (USD 740,710,000)
- **Later filings:** Revenue: shown as originally filed; later filings report different values for the same periods.

### FY2022 (period ended 2022-12-31)

- **Revenue:** $10.0B (USD 9,955,475,000)
- **Net income:** $22.4M (USD 22,389,000)
- **Total assets:** $5.4B (USD 5,386,283,000)
- **Cash and equivalents:** $69.5M (USD 69,467,000)
- **Operating cash flow:** $325.0M (USD 325,006,000)

## Recent SEC filings

- Form 8-K — filed 2026-10-09 — period 2026-10-06 — 8-K
- Form 8-K — filed 2026-09-17 — period 2026-09-16 — 8-K
- Form 8-K — filed 2026-08-17 — period 2026-08-17 — FORM 8-K
- Form 8-K — filed 2026-08-10 — period 2026-08-09 — FORM 8-K
- Form 10-Q — filed 2026-08-10 — period 2026-06-30 — 10-Q
- Form 8-K — filed 2026-08-10 — period 2026-08-10 — FORM 8-K
- Form 8-K — filed 2026-08-10 — period 2026-08-10 — FORM 8-K
- Form 8-K — filed 2026-06-25 — period 2026-06-23 — 8-K
- Form 8-K — filed 2026-06-15 — period 2026-06-09 — 8-K
- Form 8-K — filed 2026-05-22 — period 2026-05-22 — 8-K
- Form 8-K — filed 2026-05-15 — period 2026-05-14 — 8-K
- Form 10-Q — filed 2026-05-11 — period 2026-03-31 — 10-Q

---

Updated: 2026-10-23T05:02:54.863002+00:00

Canonical page: https://altss.com/profile/accendra-health-inc-va

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology